Compare Charles River Laboratories Intl. Inc (CRL) vs GoPro Inc (GPRO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs GoPro Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $288.87 (market cap $13.46B), while GoPro Inc trades at $0.58 (market cap $114.41M). The key difference: Charles River Laboratories Intl. Inc is far larger — about 117.6× GoPro Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, GoPro Inc nearer its low. Which is the better fit depends on your goals.
| CRL | GPRO | |
|---|---|---|
Market Cap | $13.46B | $114.41M |
Sector | Health | Technology |
52-Week High | $282.00 | $2.88 |
52-Week Low | $145.57 | $0.62 |
Enterprise Value | $16.30B | $173.19M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $284.37, up 2.66% today and near its 52-week high, reflecting strong bullish momentum. The stock has consistently beaten earnings estimates in recent quarters, including a Q2 2026 EPS of $3.02 versus $2.77 expected, and the company raised its full-year guidance. Despite negative net income margins, operating cash flow remains robust at $738 million in 2025. Analyst sentiment is overwhelmingly positive with 26 buy ratings and a consensus price target of $277.29.
The outlook is supported by improving biotech demand and cost controls, but high valuation multiples and recent insider selling pose risks. Earnings growth and margin expansion are key catalysts, though profitability challenges and macroeconomic sensitivity could pressure the stock. Investors should weigh strong technicals and analyst support against fundamental weaknesses and execution risks.
GoPro (GPRO) trades at $0.58, down 17.87% amid ongoing financial challenges. The company reported Q2 2026 revenue of $105 million with negative earnings, continuing a trend of revenue decline from $1.1B in 2022 to $652M in 2025. Technical indicators show bearish momentum with RSI at oversold levels, while fundamentals reveal negative net income margins and cash flow concerns despite low valuation multiples.
The outlook remains highly speculative with a strategic sale process underway. Investment opportunity exists only for event-driven speculators betting on acquisition potential, while significant risks include going concern warnings, persistent cash burn, and competitive pressures in the action camera market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About GoPro Inc
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →
